Cardio Flow

Cardio Flow announces first commercial FreedomFlow uses, appoints new COO

[Image courtesy of Cardio Flow]Cardio Flow today announced the successful completion of the first commercial cases for its FreedomFlow orbital atherectomy platform.

FreedomFlow, a device designed to treat peripheral artery disease (PAD), received FDA clearance earlier this month. Dr. Craig Walker, Dr. Pradeep Naier and Dr. McCall Walker performed the initial U.S. cases with the device. The procedures took place at the Cardiovascular Institute of the South (CIS) at the Terrebonne General Health System in Houma, Louisiana.

Cardio Flow designed FreedomFlow with a modern mechanism of action to clear plaque blockages in the arteries of the legs. The design uses the physics of angular momentum to create a spiral geometry. It puts five diamond-coated spheres in simultaneous contact with the vessel wall. The diamond-coated tip also helps ease the driveshaft through tight blockages.

The first patient treated at Terrebonne had complex arterial anatomy and multiple bl…

Cardio Flow’s FreedomFlow guidewire wins FDA clearance

[Image courtesy of Cardio Flow]Cardio Flow this week won FDA 510(k) clearance for its FreedomFlow peripheral guidewire and announced the first commercial case using the device in the U.S.

St. Paul, Minnesota-based Cardio Flow designed FreedomFlow to provide support for diagnostic and therapeutic devices in treating plaque blockages in arteries above and below the knee. It has a stainless steel core-to-tip design with a fixed distal-spring coil, both of which are silicone-coated.

Get the full story on our sister site, Medical Tubing + Extrusion.